Literature DB >> 1721820

Complement evasion strategies of microorganisms.

N R Cooper1.   

Abstract

The success of microorganisms as human pathogens stems partly from their ability to evade recognition and/or avoid destruction by complement and other natural and acquired defense mechanisms. Here, Neil Cooper reviews the various mechanisms that pathogens have evolved to evade the destructive actions of the complement system, with particular emphasis on the many remarkable examples of the duplication of complement-like structural and functional epitopes by microorganisms. Such mimicry not only enables the pathogens to avoid destruction by complement-mediated mechanisms but also, in a number of instances, facilitates infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721820     DOI: 10.1016/0167-5699(91)90010-Q

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  40 in total

1.  BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition.

Authors:  M G Barnes; A A Weiss
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.

Authors:  V Koistinen
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.

Authors:  D R Anderson; C M Carthy; J E Wilson; D Yang; D V Devine; B M McManus
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 4.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

5.  Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes.

Authors:  N Yamaguchi; M Kawasaki; Y Yamashita; K Nakashima; T Koga
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia.

Authors:  Christy L Ventura; Roger Higdon; Laura Hohmann; Daniel Martin; Eugene Kolker; H Denny Liggitt; Shawn J Skerrett; Craig E Rubens
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

7.  Binding of the Streptococcus gordonii DL1 surface protein Hsa to the host cell membrane glycoproteins CD11b, CD43, and CD50.

Authors:  Yumiko Urano-Tashiro; Ayako Yajima; Eizo Takashima; Yukihiro Takahashi; Kiyoshi Konishi
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

8.  Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica.

Authors:  L L Braga; H Ninomiya; J J McCoy; S Eacker; T Wiedmer; C Pham; S Wood; P J Sims; W A Petri
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 9.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

10.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.

Authors:  A Sahu; T R Kozel; M K Pangburn
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.